Aromha’s co-founder, Dr. Mark Albers, MD, PhD is an Assistant Professor of Neurology at Harvard Medical School ( HMS ), a neurologist at Massachusetts General Hospital ( MGH ) and leads the Albers Lab at MIND (MassGeneral Institute for Neurodegenerative Disease). Mark and Aromha work with and have grants (current and submitted) with many of the leading institutions and corporations active in neurodegeneration.

We are keenly interested in expanding our partnerships in neurodegeneration, all-cause mortality, and biological age. At Aromha, we know that alliances and collaborations are key to driving significant change.

Contact Us to be part of this exciting journey collaborating with us.

Audiologists

Audiologists are on the front line of dementia; hearing loss is one of the most important preventable lifestyle modifications.

Learn More

Clinicians

Are you interested in bringing your clientele the best brain health screening experience?

Healthcare Professionals

Wellness. Longevity. We all care about guiding our clientele.

Sales

Are you a sales star? Help people detect cognitive issues early, and get rewarded!

Distributors

Join our Distributor Partnership Program!

International Partners

Globalizing Brain Health!

Aromha is expanding globally. Join the team. Which country will you lead?

Clinical Trial Recruitment & Screening

Streamline screening process and decrease recruitment cost

Research Partners

Discover the future of early brain health screening